Cost-Effectiveness Analysis of Prognostic Gene Expression Signature-Based Stratification of Early Breast Cancer Patients

BACKGROUND: The individual risk of recurrence in hormone receptor-positive primary breast cancer patients determines whether adjuvant endocrine therapy should be combined with chemotherapy. Clinicopathological parameters and molecular tests such as EndoPredict(®) (EPclin) can support decision making...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmacoeconomics
Main Authors: Blank, Patricia R., Filipits, Martin, Dubsky, Peter, Gutzwiller, Florian, Lux, Michael P., Brase, Jan C., Weber, Karsten E., Rudas, Margaretha, Greil, Richard, Loibl, Sibylle, Szucs, Thomas D., Kronenwett, Ralf, Schwenkglenks, Matthias, Gnant, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2014
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4305105/
https://ncbi.nlm.nih.gov/pubmed/25404424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40273-014-0227-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados